ALGS - Why Aligos Therapeutics (ALGS) Stock Is Nosediving | Benzinga
Aligos Therapeutics Inc (NASDAQ: ALGS) shares are trading lower by 15.8% to $0.64 Monday afternoon after the company announced $92 million in private placement financing.
What Happened?
This funding, led by a life sciences investment firm and involving various institutional investors, including Armistice Capital and ...
ALGS) Stock Is Nosediving>Full story available on Benzinga.com